OBJECTIVE: Current NGS-based CCS platforms perform an initial whole genome amplification step, which prevents simultaneous genotyping due to shallow sequencing depth. Therefore, triploidy detection by NGS remains challenging and has only been reported based on sex chromosome copy number ratios, which fail to account for XXX triploids, and may be prone to misdiagnosis due to sample contamination or technological artefacts. Using genotyping data generated in parallel with copy number analysis from a tNGS-based CCS platform, this study aims to validate triploidy detection in human blastocysts as well as its frequency and parental origin.
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DESIGN:
Retrospective validation study.
MATERIALS AND METHODS:
Phase 1: Known diploid and triploid DNA samples were blinded and sequenced by tNGS. The average ratio of both allele frequencies of all heterozygous SNPs was calculated for each sample, where a 1:1 ratio is expected for diploid samples and 2:1 for triploids. A threshold of allele ratios (AR) was established between known triploid and diploid controls. A similar frequency of triploid blastocyst (0.31%) was observed among 1598 embryos with available parental gDNA sequenced.
CONCLUSIONS: tNGS provides higher sequencing depth in contrast to other contemporary NGS platforms, allowing for accurate SNP calling and accurate detection of triploidy. Around 15% of genetically abnormal miscarriages present a triploid karyotype, stressing the importance of validating a CCS platform capable of detecting it. In addition, this technology could be used to evaluate restoration of diploidy and heteroparentality in embryos with 1 or 3 pronuclei, potentially increasing the number of normal available blastocysts for transfer.
